Search results
Imbiotechnologies Signs Supply Agreement With Medicus Management
Digital Journal· 4 days ago("IMBiotechnologies ") is pleased to announce the signing of a supply agreement...on minimally-invasive procedures. "IMBiotechnologies' Ekobi® microspheres product is truly ...
JD Supra: President Biden Signs into Law Ten-Year Statute of Limitations for Sanctions Violations...
JD Supra· 45 minutes agoThe NSS—a package of national security and foreign aid appropriations, including for efforts in Israel, Ukraine, and the Indo-Pacific—includes various provisions impacting U.S. national security ...
Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product
Digital Journal· 6 days agoAbout Revive Therapeutics Ltd. Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 days agoBrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health ...
3 Japanese Dividend Stocks With Yields Up To 5.5%
Simply Wall St. via Yahoo Finance· 6 days agoAmid a backdrop of mixed global economic signals, Japan's stock market has shown resilience with the Nikkei 225 Index experiencing modest gains, even as...
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 49.0% in May
ETF DAILY NEWS· 3 days agoBiomerica, Inc. (NASDAQ:BMRA – Get Free Report) saw a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 175,200 shares, a decrease ...
Enlivex Therapeutics Ltd. Expected to Earn Q1 2025 Earnings of ($0.16) Per Share (NASDAQ:ENLV)
ETF DAILY NEWS· 4 days agoEnlivex Therapeutics Ltd. (NASDAQ:ENLV – Free Report) – HC Wainwright issued their Q1 2025 earnings estimates for Enlivex Therapeutics in a note issued to investors on Tuesday ...
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide...
Digital Journal· 5 days agoAbout NLS Pharmaceutics Ltd. NLS is a global development-stage biopharmaceutical company, working with a network of...is led by an experienced management team with a track ...
FIL Ltd Has $223.77 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)
ETF DAILY NEWS· 2 days agoFIL Ltd lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 0.8% during the fourth quarter, according to the company in its most ...
BridgeBio Pharma (BBIO) – Research Analysts’ Weekly Ratings Updates
ETF DAILY NEWS· 7 days agoA number of firms have modified their ratings and price targets on shares of BridgeBio Pharma (NASDAQ: BBIO) recently: 6/5/2024 – BridgeBio Pharma had its “buy” rating reaffirmed by analysts ...